Invention Grant
US09586996B2 Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
有权
Lytic-peptide-Her2 / neu（人表皮生长因子受体2）配体缀合物及其使用方法
- Patent Title: Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
- Patent Title (中): Lytic-peptide-Her2 / neu（人表皮生长因子受体2）配体缀合物及其使用方法
-
Application No.: US13695390Application Date: 2011-04-28
-
Publication No.: US09586996B2Publication Date: 2017-03-07
- Inventor: Hector Alila , Carola Leuschner
- Applicant: Hector Alila , Carola Leuschner
- Applicant Address: US TX Houston
- Assignee: ESPERANCE PHARMACEUTICALS, INC.
- Current Assignee: ESPERANCE PHARMACEUTICALS, INC.
- Current Assignee Address: US TX Houston
- Agency: Pillsbury Winthrop Shaw Pittman LLP
- Agent Robert M. Bedgood
- International Application: PCT/US2011/034338 WO 20110428
- International Announcement: WO2011/137245 WO 20111103
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K7/08 ; A61K39/00 ; A61K38/03 ; C07K14/00 ; A61K47/48 ; A61K38/10 ; A61K38/16 ; A61K45/00
Abstract:
The invention relates to conjugates that bind to Her2/neu, methods of using conjugates that bind to Her2/neu and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies that express Her2/neu.
Public/Granted literature
- US20130157961A1 LYTIC-PEPTIDE-HER2/NEU (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) LIGAND CONJUGATES AND METHODS OF USE Public/Granted day:2013-06-20
Information query
